In this episode of The Radiology Report, Daniel Arnold sits down with Dr. Daniel Durand, Chief Medical Officer at Prenuvo, to explore how whole-body MRI is reshaping the future of preventive care. As the clinical leader behind the world’s largest network dedicated to proactive imaging, Dr. Durand shares his journey from academic radiologist to healthcare executive and now, a leading voice in precision medicine.
Together, they discuss why radiologists are uniquely positioned to lead this shift from reactive care to proactive health optimization, and how Prenuvo’s data-rich approach is helping patients detect disease earlier, track meaningful changes over time, and take control of their long-term health.
In this episode, we cover:
- Why Dr. Daniel Durand chose radiology
- How Prenuvo’s whole-body MRI works
- What the Prenuvo scan can and can’t do
- The evolution from sick care to health optimization
- Prenuvo’s consumer-driven model
- The new Prenuvo Body Composition Report (imaging based)
- What’s ahead for Prenuvo
- Why Dr. Durand believes proactive imaging will become a standard part of annual care
About Dr. Daniel Durand
Dr. Dan Durand MD is the Chief Medical Officer at Prenuvo, the world’s largest and most advanced network of clinics exclusively dedicated to proactive whole-body MRI for early-stage disease detection. Dr. Durand leads the clinical and operational staff within Prenuvo’s clinics, oversees Prenuvo’s clinical research team, and serves as President of the Prenuvo Medical Group. He is dual boarded in Adult and Pediatric Radiology, having trained at Johns Hopkins University School of Medicine.
Before joining Prenuvo, Dr. Durand held leadership roles at LifeBridge Health, including enterprise Chief Clinical Officer and system-wide Chair of Radiology. During his tenure, he was instrumental in establishing the LifeBridge Health Clinically Integrated Network (LBH CIN), overseeing the care of over 150,000 individuals through value-based contracts with entities such as CMS, CMMI, CareFirst, Johns Hopkins, Cigna, and Aetna. Prior to joining LifeBridge, he held leadership roles with Johns Hopkins Medicine and Evolent Health, and earlier in his career, he worked as a consultant with McKinsey & Company. Dr. Durand serves on the adjunct faculty of Stanford University and the George Washington University and holds a courtesy appointment with the Johns Hopkins University Carey School of Business.
